INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, which is mainly caused by pathogenic variants in two particular genes: PKD1 and PKD2. ADPKD caused by variants in other genes (GANAB or IFT140) is very rare. CASE REPORT: In a 6-year-old girl examined for abdominal pain, a cystic mass in the upper part of the right kidney was detected during an abdominal ultrasound. She was referred to pediatric oncology and urology for suspicion of a tumorous mass and the condition was assessed as a cystic nephroma. A heminephrectomy was then performed on the upper cystic part of the right kidney. The histological examination was inconclusive; therefore, genetic testing was recommended. Kidney and liver cysts were detected sonographically in the mother, but DNA analysis of the PKD1 and PKD2 genes did not reveal any pathogenic variant; the cause of the pathological formation in the kidneys remained unclear. Nine years later, next-generation sequencing of a panel of genes for kidney disease was performed and a heterozygous deletion was found on chromosome 16; this included exon 13 of the IFT140 gene. The same deletion was found in the patient's mother. Currently, the patient is 14 years old and has mild sonographic findings, normal glomerular filtration, mild proteinuria, and hypertension. CONCLUSION: Pathogenic variants of the IFT140 gene very rarely cause ADPKD; however, they should be considered in all children with autosomal dominant forms of PKD and asymmetric/atypical cystic kidney involvement or negative findings of PKD1 and PKD2.

Department of Clinical and Molecular Pathology and Medical Genetics University Hospital Ostrava and Medical Faculty of the University Ostrava Ostrava Czech Republic

Department of Pediatrics University Hospital Ostrava and Medical Faculty of the University Ostrava Ostrava Czech Republic

Zobrazit více v PubMed

Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–35. PubMed

Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, et al. . Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet. 2022;109(1):136–56. PubMed PMC

Ali H, Naim M, Senum SR, AlSahow A, Bahbahani Y, Abu-Farha M, et al. . The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait. Clin Kidney J. 2023;16(2):355–66. PubMed PMC

Luithle T, Szavay P, Furtwängler R, Graf N, Fuchs J, SIOP/GPOH Study Group . Treatment of cystic nephroma and cystic partially differentiated nephroblastoma: a report from the SIOP/GPOH study group. J Urol. 2007;177(1):294–6. PubMed

Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. . Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20(1):205–12. PubMed PMC

Gimpel C, Bergmann C, Bockenhauer D, Breysem L, Cadnapaphornchai MA, Cetiner M, et al. . International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol. 2019;15(11):713–26. PubMed PMC

Massella L, Mekahli D, Paripović D, Prikhodina L, Godefroid N, Niemirska A, et al. . Prevalence of hypertension in children with early-stage ADPKD. Clin J Am Soc Nephrol. 2018;13(6):874–83. PubMed PMC

Perrault I, Saunier S, Hanein S, Filhol E, Bizet AA, Collins F, et al. . Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. Am J Hum Genet. 2012;90(5):864–70. PubMed PMC

Salhi S, Doreille A, Dancer MS, Boueilh A, Filipozzi P, El Karoui K, et al. . Monoallelic loss-of-function IFT140 pathogenic variants cause autosomal dominant polycystic kidney disease: a confirmatory study with suspicion of an additional cardiac phenotype. Am J Kidney Dis. 2024;83(5):688–91 Online ahead of print. PubMed

Orr S, Sayer JA. Many lessons still to learn about autosomal dominant polycystic kidney disease. J Rare Dis. 2023;2(1):13. PubMed PMC